● No clinical-trial readout, regulatory decision, financing orPartnershipannouncement, management change or analyst action could be dated to the session.
● No company-specific announcement was found for OKYO Pharma, and the advance reflects speculative biotech and low-float momentum.
● NoEarningsrelease, operational update, financing event or regulatory development tied to the session could be confirmed.
● NoEarningsrelease, data readout, partnership, product announcement or analyst action could be tied to the session.
● Integra LifeSciences closed at $12.68 on Friday, October 2, 2026, a decline of 21.19% on the session.
● No company-specific announcement was found for ImmunityBio, and the advance reflects speculative biotech and momentum trading.
● A review of reporting surfaced no clinical update,Earningsrelease, regulatory development, financing,Partnershipor analyst action behind the decline.
● No clinical readout, regulatory update, financing disclosure or corporate announcement tied to the session could be confirmed.
● No clinical-trial result, regulatory decision, financing,Partnershipor analyst action could be tied to the session.
● Cardiol Therapeutics closed at $1.41 on Friday, October 2, 2026, a decline of 9.62% on the session.